Form 4: Tandem Diabetes Care Executive Reports Stock Transactions
SEC Form 4 Filing
Elizabeth Anne Gasser, EVP and Chief Strategy Officer at Tandem Diabetes Care, reports multiple transactions involving company stock, including acquisitions through stock plans and tax withholdings.
Summary
- Elizabeth Anne Gasser, an executive at Tandem Diabetes Care, filed a Form 4 detailing changes in her beneficial ownership of the company's stock.
- The transactions occurred on November 15, 2024, and include the acquisition of common stock through the Employee Stock Purchase Plan (ESPP) and the vesting of restricted stock units (RSUs).
- Shares were also withheld to cover tax obligations related to the vesting of RSUs.
- Gasser acquired 619 shares at $15.64 through the ESPP.
- She also acquired 1,503, 475, and 162 shares through the vesting of different RSU grants.
- A total of 1,145 shares were withheld for tax purposes at a price of $27.34 per share.
- After these transactions, Gasser directly owns 2,369 shares and indirectly owns 11,749 shares through a family trust.
Sentiment
Score: 7
Explanation: The document reflects routine stock transactions by an executive, which is a neutral event. The ESPP participation and RSU vesting are positive indicators of employee engagement and performance, but the tax withholding is a neutral event.
Positives
- The acquisition of shares through the ESPP indicates Gasser's participation in the company's employee stock program.
- The vesting of RSUs suggests that Gasser is meeting the performance or time-based requirements of her equity grants.
Negatives
- The withholding of shares for tax purposes reduces the total number of shares Gasser ultimately receives from the vesting of RSUs.
Risks
- The stock transactions are subject to market fluctuations, which could impact the value of Gasser's holdings.
- Changes in tax laws could affect the tax implications of future stock transactions.
Industry Context
This filing is a routine disclosure of stock transactions by a company executive, which is common in publicly traded companies. It provides transparency into the ownership changes of key personnel.
Comparison to Industry Standards
- Form 4 filings are standard practice for publicly traded companies in the US, ensuring transparency of insider transactions.
- The vesting schedules of RSUs are typical for executive compensation packages, often with a mix of time-based and performance-based vesting.
- Employee stock purchase plans are a common benefit offered by many companies, allowing employees to acquire company stock at a discount.
Stakeholder Impact
- The stock transactions may have a minor impact on shareholders, as they reflect changes in insider ownership.
- The vesting of RSUs and ESPP participation can be seen as a positive for employees, indicating the company's commitment to employee compensation.
Key Dates
| Date | Description |
|---|---|
| 09/01/2011 | Date of The Gasser Family Trust. |
| 05/18/2021 | Date of RSU award under the 2013 Stock Incentive Plan. |
| 05/15/2022 | First vesting date for the RSU awarded on May 18, 2021. |
| 05/25/2022 | Date of RSU award under the 2013 Stock Incentive Plan. |
| 05/15/2023 | First vesting date for the RSU awarded on May 25, 2022. |
| 05/25/2023 | Date of RSU award under the 2023 Long-Term Incentive Plan. |
| 05/16/2024 | Start date of the ESPP purchase period. |
| 05/15/2024 | First vesting date for the RSU awarded on May 25, 2023. |
| 11/15/2024 | Date of the reported stock transactions and end date of the ESPP purchase period. |
| 11/19/2024 | Date the Form 4 was signed. |
Keywords
Tandem Diabetes Care, stock transactions, Form 4, insider trading, Elizabeth Anne Gasser, restricted stock units, employee stock purchase plan, equity compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.